Living Cell Technologies Ltd. released its earnings results on Feb 28, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.

Q: Is Living Cell Technologies Ltd. overvalued?

According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Living Cell Technologies Ltd. have?

Living Cell Technologies Ltd. has 1,687,364,500 shares outstanding.

Q: What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?

Living Cell Technologies Ltd. reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.091%.

1 Followers

1AI Stock Chart & Stats

Advanced Chart >

Day’s RangeAU$0 - AU$0

52-Week Range<AU$0.01 - AU$0.02

Previous CloseAU$0.01

Volume396.10K

Average Volume (3M)2.35M

Market Cap

AU$20.25M

Enterprise ValueAU$16.01M

Total Cash (Recent Filing)AU$4.24M

Total Debt (Recent Filing)AU$0.00

Price to Earnings (P/E)-8.6

Beta-0.41

Next Earnings

Aug 28, 2024

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,635,646,450

10 Day Avg. Volume1,418,972

30 Day Avg. Volume2,349,871

Standard Deviation0.25

R-Squared0.04

Alpha0.00902

Financial Highlights & Ratios

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Living Cell Technologies Ltd. News

PremiumCompany Announcements

Algorae Pharmaceuticals Announces Secretary Change

2d ago

PremiumCompany Announcements

ALGORAE Eyes Expansion with New Share Quotation

14d ago

PremiumCompany Announcements

ALGORAE Pharma Announces New Securities Issue

17d ago

PremiumCompany Announcements

ALGORAE Eyes Growth with New ASX Shares

18d ago

PremiumCompany Announcements

ALGORAE Ends Trading of Select Securities

18d ago

PremiumCompany Announcements

Algorae Pharmaceuticals Shares Corporate Update

23d ago

See More LVCLF News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

7.18% Insiders

0.00% Mutual Funds

0.00% Other Institutional Investors

92.82% Public Companies and

Individual Investors

Detailed Ownership Overview >

1AI FAQ

What was Living Cell Technologies Ltd.’s price range in the past 12 months?

Living Cell Technologies Ltd. lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.

What is Living Cell Technologies Ltd.’s market cap?

Currently, no data Available

When is Living Cell Technologies Ltd.’s upcoming earnings report date?

Living Cell Technologies Ltd.’s upcoming earnings report date is Aug 28, 2024 which is in 110 days.

How were Living Cell Technologies Ltd.’s earnings last quarter?

Living Cell Technologies Ltd. released its earnings results on Feb 28, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.

Is Living Cell Technologies Ltd. overvalued?

According to Wall Street analysts Living Cell Technologies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Living Cell Technologies Ltd. pay dividends?

Living Cell Technologies Ltd. does not currently pay dividends.

What is Living Cell Technologies Ltd.’s EPS estimate?

Living Cell Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Living Cell Technologies Ltd. have?

Living Cell Technologies Ltd. has 1,687,364,500 shares outstanding.

What happened to Living Cell Technologies Ltd.’s price movement after its last earnings report?

Living Cell Technologies Ltd. reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.091%.

Which hedge fund is a major shareholder of Living Cell Technologies Ltd.?

Currently, no hedge funds are holding shares in AU:1AI

---

Living Cell Technologies Ltd. Stock Smart Score

Neutral

Blogger Sentiment

Bullish

AU:1AI Sentiment 100%
Sector Average 70%

Fundamentals

Return on Equity

-68.84%

Trailing 12-Months

Asset Growth

21.41%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Living Cell Technologies Ltd.

Living Cell Technologies Ltd. is a biotechnology company. It engages in the development of treatments for implanting healthy living cells to replace or repair diseased or damaged organs for life threatening diseases. The company was founded by Robert Bartlett Elliot and David Collinson in 1987 and is headquartered in Auckland, New Zealand.

---